Chronic hepatitis C and persistent occult hepatitis C virus infection are characterized by distinct immune cell cytokine expression profiles

Journal of Viral Hepatitis

Volumn 16, Issue 8, 2009, Pages 547-556

  Pham, T N Q ^a   Mercer, S E ^a   Michalak, T I ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

Antiviral immune response; Cytokines; HCV lymphotropism; HCV persistence; Immune cells infection

Indexed keywords

ALPHA INTERFERON; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; RNA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOCOMPETENT CELL; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS REPLICATION;

ADULT; AGED; BLOOD; CYTOKINES; FEMALE; GENOTYPE; HEPATITIS B VIRUS; HEPATITIS C, CHRONIC; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 68749086303     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2009.01092.x     Document Type: Article

References (43)

1. Lavanchy D, Purcell R, Hollinger FB, et al. Global surveillance and control of hepatitis C. J Viral Hepat 1999 6 : 35 47.
2. Alberti A, Chemello L, Benvegnu L. Natural history of hepatitis C. J Hepatol 1999 31 : 17 24.
3. Zignego AL, Ferri C, Giannini C, et al. Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma: evidence for a pathogenetic role. Arch Virol 1997 142 : 545 555.
4. Pham TNQ, MacParland SA, Mulrooney PM, Cooksley H, Naoumov NV, Michalak TI. Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C. J Virol 2004 78 : 5867 5874.
5. Radkowski M, Gallegos-Orozco JF, Jablonska J, et al. Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C. Hepatology 2005 41 : 106 114.
6. Castillo I, Rodriguez-Inigo E, Lopez-Alcorocho JM, Pardo M, Bartolome J, Carreno V. Hepatitis C virus replicates in the liver of patients who have a sustained response to antiviral treatment. Clin Infect Dis 2006 43 : 1277 1283.
7. Ciancio A, Smedile A, Giordanino C, et al. Long term follow-up of previous hepatitis C virus positive non-responders to interferon monotherapy successfully re-treated with combination therapy: are they really cured? J Clin Virol 2006 36 : S141.
8. Di Liberto G, Roque-Afonso A, Fallot G, Samuel D, Feray C. Clinical and therapeutic implications of HCV compartmentalization. J Clin Virol 2006 36 : S114.
9. Gallegos-Orozco JF, Rakela J, Rosati MJ, Vargas HE, Balan V. Persistence of hepatitis C virus in peripheral blood mononuclear cells of sustained viral responders to pegylated interferon and ribavirin therapy. Dig Dis Sci 2008 53 : 2564 2568.
10. Pham TNQ, Michalak TI. Occult persistence and lymphotropism of hepatitis C virus infection. W J Gastroenterol 2008 14 : 2789 2793.
11. Blackard JT, Kemmer N, Sherman KE. Extrahepatic replication of HCV: Insights into clinical manifestations and biological consequences. Hepatology 2006 44 : 15 22.
12. Pham TNQ, King D, MacParland SA, et al. Hepatitis C virus replicates in the same immune cell subsets in chronic hepatitis C and occult infection. Gastroenterology 2008 134 : 812 822.
13. MacParland SA, Pham TNQ, Gujar SA, Michalak TI. De novo infection and propagation of wild-type Hepatitis C virus in human T lymphocytes in vitro. J Gen Virol 2006 87 : 3577 3586.
14. Pal S, Sullivan DG, Kim S, et al. Productive replication of hepatitis C virus in perihepatic lymph nodes in vivo: implications of HCV lymphotropism. Gastroenterology 2006 130 : 1107 1116.
15. Goutagny N, Vieux C, Decullier E, et al. Quantification and functional analysis of plasmacytoid dendritic cells in patients with chronic hepatitis C virus infection. J Infect Dis 2004 189 : 1646 1655.
16. Radkowski M, Bednarska A, Horban A, et al. Infection of primary human macrophages with hepatitis C virus in vitro: induction of tumour necrosis factor-alpha and interleukin 8. J Gen Virol 2004 85 : 47 59.
17. Gruner NH, Gerlach TJ, Jung MC, et al. Association of hepatitis C virus-specific CD8(+) T cells with viral clearance in acute hepatitis C. J Infect Dis 2000 181 : 1528 1536.
18. Takaki A, Wiese M, Maertens G, et al. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med 2000 6 : 578 582.
19. Lechner F, Wong DKH, Dunbar PR, et al. Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 2000 191 : 1499 1512.
20. Sarih M, Bouchrit N, Benslimane A. Different cytokine profiles of peripheral blood mononuclear cells from patients with persistent and self-limited hepatitis C virus infection. Immunol Lett 2000 74 : 117 120.
21. Tsai SL, Liaw YF, Chen MH, Huang CY, Kuo GC. Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity. Hepatology 1997 25 : 449 458.
22. Brooks DG, Trifilo MJ, Edelmann KH, Teyton L, McGavern DB, Oldstone MBA. Interleukin-10 determines viral clearance or persistence in vivo. Nat Med 2006 12 : 1301 1309.
23. Mistchenko AS, Fornari MC, Viegas M, Barrero PR, Diez RA. Detection of interleukin 10 in cerebrospinal fluid of patients with subacute sclerosing panencephalitis. J Neurovirol 2005 11 : 66 69.
24. Khabar KS, Al Zoghaibi F, et al. The alpha chemokine, interleukin 8, inhibits the antiviral action of interferon alpha. J Exp Med 1997 186 : 1077 1085.
25. Polyak SJ, Khabar KS, Paschal DM, et al. Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response. J Virol 2001 75 : 6095 6106.
26. Polyak SJ, Khabar KS, Rezeiq M, Gretch DR. Elevated levels of interleukin-8 in serum are associated with hepatitis C virus infection and resistance to interferon therapy. J Virol 2001 75 : 6209 6211.
27. Mihm U, Herrmann E, Sarrazin U, et al. Association of serum interleukin-8 with virologic response to antiviral therapy in patients with chronic hepatitis C. J Hepatol 2004 40 : 845 852.
28. Pham TNQ, Mulrooney-Cousins PM, Mercer SE, et al. Antagonistic expression of hepatitis C virus and alpha interferon in lymphoid cells during persistent occult infection. J Viral Hepat 2007 14 : 537 548.
29. Pham TNQ, MacParland SA, Coffin CS, Lee SS, Bursey FR, Michalak TI. Mitogen-induced upregulation of hepatitis C virus expression in human lymphoid cells. J Gen Virol 2005 86 : 657 666.
30. Yu YM, Rabinowitz R, Steinitz M, Schlesinger M. Correlation between the expression of CD4 and the level of CD4 mRNA in human B-cell lines. Cell Immunol 2002 215 : 78 86.
31. Howe JG, Crouch J, Cooper D, Smith BR. Real-time quantitative reverse transcription-PCR for cyclin D 1 mRNA in blood, marrow, and tissue specimens for diagnosis of mantle cell lymphoma. Clin Chem 2004 50 : 80 87.
32. Kanaya S, Nemoto E, Ogawa T, Shimauchi H. Porphyromonas gingivalis lipopolysaccharides induce maturation of dendritic cells with CD14(+)CD16(+) phenotype. Eur J Immunol 2004 34 : 1451 1460.
33. Masante C, Mahias K, Lourenco S, et al. Seven nucleotide changes characteristic of the hepatitis C virus genotype 3 5′ untranslated region: correlation with reduced in vitro replication. J Gen Virol 2008 89 : 212 221.
34. Laporte J, Bain C, Maurel P, Inchauspe G, Agut H, Cahour A. Differential distribution and internal translation efficiency of hepatitis C virus quasispecies present in dendritic and liver cells. Blood 2003 101 : 52 57.
35. Kawai T, Akira S. Innate immune recognition of viral infection. Nat Immunol 2006 7 : 131 137. (Pubitemid 43135878)
36. Randall G, Chen LM, Panis M, et al. Silencing of USP18 potentiates the antiviral activity of interferon against hepatitis C virus infection. Gastroenterology 2006 131 : 1584 1591.
37. Asahina Y, Izumi N, Hirayama I, et al. Potential relevance of cytoplasmic viral sensors and related regulators involving innate immunity in antiviral response. Gastroenterology 2008 134 : 1396 1405.
38. Malakhova OA, Kim KI, Luo JK, et al. UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity. EMBO J 2006 25 : 2358 2367.
39. Romagnani S. Biology of human TH1 and TH2 cells. J Clin Immunol 1995 15 : 121 129.
40. Filippi CM, von Herrath MG. IL-10 and the resolution of infections. J Pathol 2008 214 : 224 230.
41. Nelson DR, Tu ZK, Soldevila-Pico C, et al. Long-term interleukin 10 therapy in chronic hepatitis C patients has a proviral and anti-inflammatory effect. Hepatology 2003 38 : 859 868.
42. Friedland JS. Chemokines in viral disease. Res Virol 1996 147 : 131 138.
43. Shimoda K, Begum MA, Shibuta K, et al. Interleukin-8 and hIRH (SDF1-alpha/PBSF) mRNA expression and histological activity index in patients with chronic hepatitis C. Hepatology 1998 28 : 108 115.